IRF2 and neoplasm: Our above findings indicated IFNβ-regulated PD-1 expression through the pSTAT1-IRF2 axis in three different types of myeloid cells (RAW264.7 cells, tumor-infiltrating CD11b+ cells and bone marrow-derived MDSCs).